3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Melanoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Exostoses, Multiple Hereditary
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Breast Cancer Lymphedema
1
BTC
1
Interventions
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Biopsy
5
Temozolomide
4
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Cyclophosphamide
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.